Tumors are unique organs defined by abnormal signaling and context

Seminars in Cancer Biology

Volumn 11, Issue 2, 2001, Pages 87-95

  Radisky, Derek ^a   Hagios, Carmen ^a   Bissell, Mina J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epithelial stromal interactions; Microenvironment; Tumor progression

Indexed keywords

CANCER CELL; CANCER RESEARCH; CARCINOGENESIS; CELL INTERACTION; ENVIRONMENTAL FACTOR; GENE MUTATION; NONHUMAN; ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; STROMA CELL; TUMOR GROWTH;

EID: 0035003342     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.2000.0360     Document Type: Article

References (120)

1. Genetic instability and darwinian selection in tumors
2. The hallmarks of cancer
3. Tumors: Wounds that do not heal
4. The multiple roles of tumor stroma
5. The role of stroma in prostatic carcinogenesis
6. How does extracellular matrix direct gene expression?
7. Structure and biological activity of the extracellular matrix
8. Integrin signaling and cell growth control
9. Stuck on the ECM
10. Extracellular matrix remodeling and cellular differentiation
11. The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling
12. The structural and mechanical complexity of cell-growth control
13. Signal transduction and signal modulation by cell adhesion receptors: The role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins
14. Ligand binding to integrins
15. A role for dystroglycan in basement membrane assembly
16. Integrin modulation by lateral association
17. Cell adhesion molecules, signal transduction and cell growth
18. Integrin signaling
19. Extracellular matrix and integrin signalling: The shape of things to come
20. Basement membranes: Putting up the barriers
21. Basement membrane synthesis and degradation
22. Form and function: The laminin family of heterotrimers
23. Matrix proteoglycans: From molecular design to cellular function
24. Assembly of type IV collagen
25. New functions for non-collagenous domains of human collagen type IV
26. Nidogen-2: A new basement membrane protein with diverse binding properties
27. Renal basement membrane components
28. Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice
29. Ultrastructural triple localization of laminin-1, nidogen-1, and collagen type IV helps elucidate basement membrane structure in vivo
30. In vivo functions of integrins: Lessons from null mutations in mice
31. Targeted mutations in cell adhesion genes: What have we learned from them?
32. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation
33. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
34. Stromal cell expression of matrix-degrading protease systems in human cancer
35. Intestinal inflammation: A complex interplay of immune and nonimmune interactions
36. Cancer invasion and tissue-remodeling-cooperation of protease systems and cell types
37. The biochemistry of cancer dissemination
38. Cell surface chondroitin sulfate proteoglycans in tumor cell adhesion, motility, and invasion
39. ECM signalling: Orchestrating cell behavior and misbehavior
40. A proinflammatory cytokine inhibits p53 tumor suppressor activity
41. Tenascin-C suppresses rho activation
42. Extracellular matrix in renal cell carcinomas
43. Bidirectional signaling between the cytoskeleton and integrins
44. Tenascin-C matrix assembly in oral squamous cell carcinoma
45. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo
46. Recent insights into the role of integrins in cancer metastasis
47. Growth factors in the extracellular matrix
48. Role of transforming growth factor beta in human disease
49. Stromal reaction in cancer tissue: Pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions
50. Patterns and emerging mechanisms of the angiogenesis switch during tumorigenesis
51. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
52. Changing views of the role of matrix metalloproteinases in metastasis
53. Interactions between cancer cells and the endothelium in metastasis
54. Accelerated growth of melanomas after specific immune destruction of tumor stroma in a mouse model
55. Differences in latency and indicibility of mouse skin melanomas depending on the age and anatomic site of the skin
56. At the crossroads of inflammation and tumorigenesis
57. Helicobactar pylori infection and carcinogenesis of the stomach
58. Altered states: Involvement of phosphoryated CagA in the induction of host cellular growth changes by Helicobacter pylori
59. Helicobacter pylori infection and gastric lymphoma
60. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis
61. Pathogenesis, diagnosis, and management of hepatitis C
62. Hepatitis C: The clinical spectrum of the disease
63. Molecular mechanisms and pathways in bladder cancer development and progression
64. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus
65. Clinical epidemiology and natural history of gastroesophageal reflux disease
66. Chronic pancreatitis and other risk factors for pancreatic cancer
67. Hereditary pancreatitis and pancreatic carcinoma
68. Ulcerative colitis
69. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma
70. Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia
71. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
72. Radial scars in benign breast-biopsy specimens and the risk of breast cancer
73. Does idiopathic pulmonary, fibrosis increase lung cancer risk?
74. Mechanisms in the pathogenesis of asbestosis and silicosis
75. Cyclooxygenase-2 and carcinogenesis
76. Occurrence of a fetal fibroblast phenotype in familial breast cancer
77. Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics
78. Altered biochemical properties of actin in normal skin fibroblasts from individuals predisposed to dominantly expressed cancers
79. Abnormal properties of skin fibroblasts from patients with breast cancer
80. Further characterization of the defects of skin fibroblasts from cancer patients
81. Landscaping the cancer terrain
82. Mutations in the SMAD4/DPC4 gene in juvenile polyposis
83. A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria
84. Endometrial polyps with predominant stromal component are characterized by a t(6;14)(p21;q24) translocation
85. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis
86. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ('clinging ductal carcinoma in situ')
87. Targeted expression of stromelysin-1 in mammary gland provides evidence for proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression
88. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development
89. Mammary gland formation in transgenic mice overexpressing stromelysin-1
90. The stroreal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis
91. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter
92. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties
93. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells
94. The matrix metalloproteinase matrilysin influences early-stage mammary: Tumorigenesis
95. Stromelysin-3 expression promotes tumor take in nude mice
96. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy
97. Genetic events and the role of TGF-β in epithelial tumor progression
98. Integration of positive and negative growth signals during ras pathway activation in vivo
99. Loss of heterozygosity in normal tissue adjacent to breast carcinomas
100. Loss of heterozygosity on chromosome 11p15 during histological progression in microdissected ductal carcinoma of the breast
101. Loss of heterozygosity in fibrocystic change of the breast: Genetic relationship between benign proliferative lesions and associated carcinomas
102. Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources
103. Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in coculture
104. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
105. Tissue structure, nuclear organization, and gene expression in normal and malignant breast
106. A new diploid nontumirgenic human breast epithelial cell line isolated and propagated in chemically defined medium
107. Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-α and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements
108. Gradual selection of a cellular clone presenting a mutation at codon 179 of the p53 gene during establishment of the immortalized human breast epithelial cell line HMT-3522
109. In vitro karyotype evolution in a cell line established from nonmalignant human mammary epithelium
110. Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal
111. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells
112. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies
113. Tissue phenotype depends on reciprocal interactions between the extracellular matrix and the structural organization of the nucleus
114. Reciprocal interactions between β-1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology
115. AZU-1: A candidate breast tumor suppressor and biomarker for tumor progression
116. Keratinocyte growth regulation in definied organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts
117. Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes
118. Cell interactions control the fate of malignant keratinocytes in an organotypic model of early neoplasia
119. Normal keratinocytes suppress early stages of neoplastic progression in stratified epithelium
120. The war on cancer